Compare Adaptive Biotechnologies Corp (ADPT) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Lithium Americas Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Lithium Americas Corp trades at $3.29 (market cap $1.18B). The key difference: Adaptive Biotechnologies Corp is far larger — about 3.4× Lithium Americas Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| ADPT | LAC | |
|---|---|---|
Market Cap | $4.04B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $25.45 | $10.05 |
52-Week Low | $12.30 | $2.71 |
Enterprise Value | $4.10B | $1.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
